Brazil Virtual Clinical Trials Market Size & Outlook
Brazil virtual clinical trials market, 2017-2030 (US$M)
Related Markets
Brazil virtual clinical trials market highlights
- The Brazil virtual clinical trials market generated a revenue of USD 167.5 million in 2022 and is expected to reach USD 256.0 million by 2030.
- The Brazil market is expected to grow at a CAGR of 5.4% from 2023 to 2030.
- In terms of segment, interventional was the largest revenue generating study design in 2022.
- Interventional is the most lucrative study design segment registering the fastest growth during the forecast period.
Virtual clinical trials market data book summary
| Market revenue in 2022 | USD 167.5 million |
| Market revenue in 2030 | USD 256.0 million |
| Growth rate | 5.4% (CAGR from 2022 to 2030) |
| Largest segment | Interventional |
| Fastest growing segment | Interventional |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Interventional, Observational, Expanded Access |
| Key market players worldwide | Icon PLC, PAREXEL, IQVIA Holdings Inc, Labcorp Holdings Inc, LEO Pharma, Medidata, Oracle Corp, Signant Health |
Other key industry trends
- In terms of revenue, Brazil accounted for 2.0% of the global virtual clinical trials market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil virtual clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- Argentina is the fastest growing regional market in Latin America and is projected to reach USD 142.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Virtual Clinical Trials Market Scope
Virtual Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil virtual clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to virtual clinical trials market will help companies and investors design strategic landscapes.
Interventional was the largest segment with a revenue share of 46.75% in 2022. Horizon Databook has segmented the Brazil virtual clinical trials market based on interventional, observational, expanded access covering the revenue growth of each sub-segment from 2017 to 2030.
Brazil virtual clinical trials market accounted for 33.8% of market share in 2020. Brazil is expected to dominate the market during the forecast period. It is expected to be the target market for international virtual clinical trial companies, thereby boosting the demand for regulatory services during the forecast period.
In addition, growing demand for virtual clinical trials and presence of stable regulatory system are among the factors expected to boost the market in Brazil. A lot of clinical trial work was halted due to the COVID-19 pandemic.
As of 3rd February 2021, there are over 9,286,256 coronavirus cases and over 226,383 deaths have occurred in Brazil due to the pandemic. Virtual clinical trials offer a safe & costeffective route to complete existing clinical trials in the country as well as initiate new ones.
Reasons to subscribe to Brazil virtual clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil virtual clinical trials market databook
-
Our clientele includes a mix of virtual clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil virtual clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Brazil virtual clinical trials market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil virtual clinical trials market size, by study design, 2017-2030 (US$M)
Brazil Virtual Clinical Trials Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
